SUPERCOMNET TECHNOLOGIES BHD

KLSE (MYR): SCOMNET (0001)

You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!

Last Price

1.28

Today's Change

+0.01 (0.79%)

Day's Change

1.25 - 1.29

Trading Volume

130,500

Financial
Market Cap

Market Cap

1,102 Million

NOSH

861 Million

Latest Quarter

Latest Quarter

30-Jun-2024 [#2]

Announcement Date

27-Aug-2024

Next Quarter

30-Sep-2024

Est. Ann. Date

22-Nov-2024

Est. Ann. Due Date

29-Nov-2024

QoQ | YoY

4.43% | 15.18%

T4Q Result

Revenue | NP to SH

141,782.000 | 31,866.000

RPS | P/RPS

16.47 Cent | 7.77

EPS | P/E | EY

3.70 Cent | 34.57 | 2.89%

DPS | DY | Payout %

1.87 Cent | 1.46% | 50.52%

NAPS | P/NAPS

0.50 | 2.58

QoQ | YoY

3.6% | 4.42%

NP Margin | ROE

22.48% | 7.48%

F.Y. | Ann. Date

30-Jun-2024 | 27-Aug-2024

Latest Audited Result

Latest Audited Result

31-Dec-2023

Announcement Date

30-Apr-2024

Next Audited Result

31-Dec-2024

Est. Ann. Date

30-Apr-2025

Est. Ann. Due Date

29-Jun-2025

Annual (Unaudited)

Revenue | NP to SH

138,055.000 | 29,727.000

RPS | P/RPS

16.04 Cent | 7.98

EPS | P/E | EY

3.45 Cent | 37.06 | 2.70%

DPS | DY | Payout %

1.80 Cent | 1.41% | 52.22%

NAPS | P/NAPS

0.42 | 3.02

YoY

-9.93%

NP Margin | ROE

21.53% | 8.15%

F.Y. | Ann. Date

31-Dec-2023 | 28-Feb-2024

Annualized Result

Revenue | NP to SH

148,850.000 | 32,918.000

RPS | P/RPS

17.30 Cent | 7.40

EPS | P/E | EY

3.82 Cent | 33.46 | 2.99%

DPS | DY | Payout %

-

NAPS | P/NAPS

-

QoQ | YoY

2.22% | 14.94%

NP Margin | ROE

22.11% | 7.72%

F.Y. | Ann. Date

30-Jun-2024 | 27-Aug-2024

Business Process

Trailing 4 Quarters Trailing 8 Quarters
Available Quarters 4 Quarters 8 Quarters
Continuous Quarters Of Revenue Growth 3 / 4 75.00% 3 / 8 37.50%
Total Positive Profit Years 4 / 4 100.00% 8 / 8 100.00%
Continuous Quarters Of Positive Profit 4 / 4 100.00% 8 / 8 100.00%
Continuous Quarters Of Profit Growth 4 / 4 100.00% 6 / 8 75.00%
Continuous Quarters Of Adjusted EPS Growth 4 / 4 100.00% 6 / 8 75.00%
Total Dividend Years 2 / 4 50.00% 4 / 8 50.00%
Continuous Quarters Of Dividend 0 / 4 0.00% 0 / 8 0.00%
Continuous Quarters Of Dividend Growth 0 / 4 0.00% 0 / 8 0.00%
Continuous Quarters Of Adjusted Dps Growth 0 / 4 0.00% 0 / 8 0.00%
Average ROE 2.07% 2.17%
Average Net Profit Margin 22.49% 21.17%

Last 5 Financial Years Last 10 Financial Years
Available Years 5 Years 10 Years
Continuous Quarters Of Revenue Growth 0 / 5 0.00% 0 / 10 0.00%
Total Positive Profit Years 5 / 5 100.00% 10 / 10 100.00%
Continuous Quarters Of Positive Profit 5 / 5 100.00% 10 / 10 100.00%
Continuous Quarters Of Profit Growth 0 / 5 0.00% 0 / 10 0.00%
Continuous Quarters Of Adjusted EPS Growth 0 / 5 0.00% 0 / 10 0.00%
Total Dividend Years 5 / 5 100.00% 6 / 10 60.00%
Continuous Quarters Of Dividend 5 / 5 100.00% 5 / 10 50.00%
Continuous Quarters Of Dividend Growth 4 / 5 80.00% 4 / 10 40.00%
Continuous Quarters Of Adjusted Dps Growth 5 / 5 100.00% 5 / 10 50.00%
Average ROE 8.98% 7.47%
Average Net Profit Margin 18.53% 13.25%
Key Result

T4Q Annualized Annual (Unaudited) Last 10 FY Average Last 5 FY Average
Revenue 141,782 148,850 138,055 91,482 138,640
NP to SH 31,866 32,918 29,727 15,029 25,885
Dividend 16,097 25,075 15,524 6,292 12,389
Adjusted EPS 3.70 3.82 3.45 1.75 3.01
Adjusted DPS 1.87 2.91 1.80 0.73 1.44

NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share

All figures in '000 unless specified.

EPS & DPS's figures in Cent.

Growth

LQ QoQ LQ YoY CQ YoY LQ vs Average of T4Q LQ vs Average of T8Q
Revenue 5.93% 14.85% 5.27% 8.01% 3.83%
NP to Owner 4.43% 15.18% 14.94% 5.54% 7.82%
Dividend 0.00% 0.00% 7.77% 0.00% 0.00%
Adjusted EPS 4.43% 15.18% 14.94% 5.54% 7.82%
Adjusted DPS 0.00% 0.00% 7.77% 0.00% 0.00%

LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year

T4Q vs LFY T4Q vs AL5FY T4Q vs AL10FY AQR vs LFY AQR vs AL5FY AQR vs AL10FY LFY YoY LFY vs AL5FY LFY vs AL10FY
Revenue 2.70% 2.27% 54.98% 7.82% 7.36% 62.71% -12.80% -0.42% 50.91%
NP to Owner 7.20% 23.10% 112.02% 10.73% 27.17% 119.02% -9.93% 14.84% 97.79%
Dividend 3.69% 29.93% 155.84% 61.52% 102.39% 298.52% 1.91% 25.30% 146.73%
Adjusted EPS 7.20% 23.10% 112.02% 10.73% 27.17% 119.02% -9.93% 14.84% 97.79%
Adjusted DPS 3.69% 29.93% 155.84% 61.52% 102.39% 298.52% 1.91% 25.30% 146.73%

T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year

Discussions
7 people like this. Showing 50 of 4,414 comments

t_nike2002

Good prospect especially in medical and automotive sector.
Price is holding up and good upside moving forward

2024-01-12 11:43

INVEST_AA

Fruitcake with no substance statement

2024-01-15 15:44

Jerry87

Can you count on future projects when known products are already hopeless?

2024-01-16 10:07

Xcalibre

Automotive to Fully Recover by 2Q24
Management shared that 4Q23 automotive contribution would remain flat QoQ but full recovery is expected to happen by either 1Q24 or 2Q24. We understand that Scomnet’s customer, Stellantis is evaluating Gurun’s potential to be a regional hub for battery-electric vehicles (BEVs) for domestic and export markets. In essence, we believe the expansion of Stellantis in ASEAN (via Gurun, Kedah) will bode well for Scomnet.

In addition, Scomnet has been approached by a European automotive player to produce wire harness for Chrysler models in the US market. If successful, the first project is expected to begin in March or April 2024 and contribute around RM10-15mn sales per annum.

2024-01-17 14:40

Xcalibre

Medical Segment Sets to Grow Further
Moving into 4Q23, the group is confident that the medical segment contribution will increase by 15-20% QoQ driven by higher sales to Edward (40% of 3Q23 revenue) and recovery in orders from Ambu (29% of 3Q23 revenue). We note that Supercomnet has been chosen by Edwards Lifesciences (market cap of above USD50bn) as the best quality supplier (more than 700 suppliers) and achieved gold status in 2023. Edward will be using more digital smart cable (from analog cable) for its products such as its inbuilt PCB Board somewhere in the middle of 2024. For Ambu, the growth will come from endoscopes, gastroscopes and colonoscope (US FDA approved in Sep-23).

2024-01-17 14:40

Xcalibre

Full of potential..and lots of upsides

2024-01-17 14:40

Xcalibre

Investors are smart enough to know who’s the tin kosong (ie fruitcake) who just know how to make noise and post statements with NO substance…

2024-01-17 19:36

fruitcake

ok sorry. i delete all. good luck & all the best

2024-01-17 20:20

fruitcake

@xcalibre, is the price gone beyond sight?

2024-01-22 09:39

catalan

1 day down 3 cents, next day up 3 cents.

2024-01-24 17:33

TrendSculptor

wow, wat happened? Why the directors disposed the shares continuously?

2024-02-08 10:00

Michael Kwok

Buy call scomnet 1.30
Tp 1.80 range.
Is it real.will say yes.ini kali lah.
15/2/24 3.55pm

2024-02-15 15:55

Michael Kwok

Post removed.Why?

2024-02-15 15:58

TrendSculptor

Good Q4 result can be expected from Scomnet?

2024-02-20 15:46

NgWS90

Probably as Ambu's order has been recovering since the third quarter of last year

2024-02-26 15:51

fruitcake

loose cannons...taiwanese???

2024-03-01 12:32

NgWS90

Geopolitical risk is more likely ...

2024-03-04 15:13

Xcalibre

Price is rather high (PE 34x) while future upside is not that great..
Mermaid orders would be halted in April this year. Though it’s mentioned to be resumed by Sept when internal dispute is settled, there is uncertainty whether the dispute can be settled by then..

better wait for it the price to be cheaper first then only enter..

2024-03-06 10:07

NgWS90

What's the fair price of Scomnet to you, Xcalibre? 🙂🙂

2024-03-07 11:40

c328

Be cautious of this company.
Between August 2020 and March 2024,
they have continually added 170,117,400 shares through additional listings, which dilutes shareholder benefits. This trend of adding approximately 3,956,218 shares per month continues.

The management of this listed company is not sincere in fostering business growth;
instead, they manipulate share units for their own benefit.

2024-03-07 19:35

jackyjay

c328 ,
the Company issued FREE warrant of 1:3 to all existing shareholders on 2019, then they are eligible to convert warrant at RM0.65 per share (which the price are similar at the mother share price at 2019). So the convertion is a REWARD to shareholders who hold long term.

2024-03-08 08:14

NgWS90

I guess c328 missed out the bonus issue and became upset. ha

2024-03-08 18:26

c328

ha.. lets the market take time to digest all the dilution impact and production line impact first.

2024-03-08 23:36

NgWS90

Directors bought back the shares. Got good news ?

2024-03-14 16:17

c328

boss always bought shares around +/- 1.20, boss knows how to earn money.

2024-03-18 11:56

NgWS90

Because boss also knows his own business very well 😁

2024-03-20 10:29

NgWS90

Scomnet is waking up and moving up

2024-04-03 17:31

NgWS90

EPF starts to collect Scomnet. It's a hint 😉

2024-04-18 07:30

NgWS90

Slide back down when it hits 1 year high price (Rm1.55) 😅

2024-04-25 15:50

Nepo

omg today volume huge.
now only two distinct directions :-
1) Fly uppp and away
2) Crash and hard landing

You have to bet which direction it goes..

2024-04-29 16:04

c328

confirm up trend

2024-04-29 23:15

c328

nope. it's normal, when have Exercise of Warrants - 2,224,166 shares at 0.650. Just wait.

2024-05-08 10:58

cherry88

Watch out for results announcement today or tomorrow. More excitment ahead

2024-05-20 15:57

NgWS90

Q1 result was out. Net profit improved QoQ and YoY due to increased in sales of medical products with better profit margin

2024-05-21 10:10

NgWS90

Sell at this price...? no way 😁 wait it move higher a bit 1st

2024-05-27 10:52

mf

Europe stocks extend losses after worst session for a month; Royal Mail owner IDS up 4% on sale agreement
Jenni Reid

2024-05-29 23:01

NgWS90

Scomnet is expected to rake in net profit of RM39.15 million this year, according to Bloomberg, compared to RM29.73 million in the previous year.

2024-06-04 17:26

NgWS90

Nice, EPF keeps on collecting. Breaking RM1.50 next week is possible 😊

2024-06-07 21:12

dchin472

scomnet gogogo

2024-06-12 09:58

NgWS90

Interesting, it went down instead after the agm ...

2024-06-13 17:33

NgWS90

Scomnet went back up after EPF collected continuously. ha

2024-07-01 17:09

NgWS90

Supercomnet looks for another shot in the arm in medical segment
https://theedgemalaysia.com/node/719123

2024-07-23 20:20

NgWS90

Return to the slow upward trend this Scomnet 🤗

1 month ago

calvinfong_them

What happen to this stock??? keep dropping

1 month ago

NgWS90

Due to ESOS I think ...

1 month ago

Post a Comment